Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

Mary Eapen; Jianqun Kou; Martin Andreansky; Monica Bhatia; Joel Brochstein; Sonali Chaudhury; Ann E. Haight; Hilary Haines; David Jacobsohn; Jennifer Jaroscak; Kimberly A. Kasow; Lakshmanan Krishnamurti; John E. Levine; Kathryn Leung; David Margolis; Lolie C. Yu; Mary M. Horowitz; Naynesh Kamani; Mark C. Walters; Shalini Shenoy

doi:10.1002/ajh.27251

Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein, Sonali Chaudhury, Ann E. Haight, Hilary Haines, David Jacobsohn, Jennifer Jaroscak, Kimberly A. Kasow, Lakshmanan Krishnamurti, John E. Levine, Kathryn Leung, David Margolis, Lolie C. Yu, Mary M. Horowitz, Naynesh Kamani, Mark C. Walters, Shalini Shenoy^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	785-788
Number of pages	4
Journal	American Journal of Hematology
Volume	99
Issue number	4
DOIs	https://doi.org/10.1002/ajh.27251
State	Published - Apr 2024

Funding

Support for this study was provided by grant #U10HL069294 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute, along with funding by the National Marrow Donor Program, the Sickle Cell Disease Clinical Research Network, and the National Center on Minority Health and Health Disparities. The Center for International Blood and Marrow Transplant Research is supported primarily by grant #U24\u2010CA76518 from the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Institute of Allergy and Infectious Diseases and contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the above mentioned parties.

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.27251

Cite this

Eapen, M., Kou, J., Andreansky, M., Bhatia, M., Brochstein, J., Chaudhury, S., Haight, A. E., Haines, H., Jacobsohn, D., Jaroscak, J., Kasow, K. A., Krishnamurti, L., Levine, J. E., Leung, K., Margolis, D., Yu, L. C., Horowitz, M. M., Kamani, N., Walters, M. C., & Shenoy, S. (2024). Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. American Journal of Hematology, 99(4), 785-788. https://doi.org/10.1002/ajh.27251

@article{7ee8b6412ba84d9f83c259b17592fbf7,

title = "Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial",

author = "Mary Eapen and Jianqun Kou and Martin Andreansky and Monica Bhatia and Joel Brochstein and Sonali Chaudhury and Haight, {Ann E.} and Hilary Haines and David Jacobsohn and Jennifer Jaroscak and Kasow, {Kimberly A.} and Lakshmanan Krishnamurti and Levine, {John E.} and Kathryn Leung and David Margolis and Yu, {Lolie C.} and Horowitz, {Mary M.} and Naynesh Kamani and Walters, {Mark C.} and Shalini Shenoy",

year = "2024",

month = apr,

doi = "10.1002/ajh.27251",

language = "English (US)",

volume = "99",

pages = "785--788",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

Eapen, M, Kou, J, Andreansky, M, Bhatia, M, Brochstein, J, Chaudhury, S, Haight, AE, Haines, H, Jacobsohn, D, Jaroscak, J, Kasow, KA, Krishnamurti, L, Levine, JE, Leung, K, Margolis, D, Yu, LC, Horowitz, MM, Kamani, N, Walters, MC & Shenoy, S 2024, 'Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial', American Journal of Hematology, vol. 99, no. 4, pp. 785-788. https://doi.org/10.1002/ajh.27251

TY - JOUR

T1 - Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

AU - Eapen, Mary

AU - Kou, Jianqun

AU - Andreansky, Martin

AU - Bhatia, Monica

AU - Brochstein, Joel

AU - Chaudhury, Sonali

AU - Haight, Ann E.

AU - Haines, Hilary

AU - Jacobsohn, David

AU - Jaroscak, Jennifer

AU - Kasow, Kimberly A.

AU - Krishnamurti, Lakshmanan

AU - Levine, John E.

AU - Leung, Kathryn

AU - Margolis, David

AU - Yu, Lolie C.

AU - Horowitz, Mary M.

AU - Kamani, Naynesh

AU - Walters, Mark C.

AU - Shenoy, Shalini

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85185139592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85185139592&partnerID=8YFLogxK

U2 - 10.1002/ajh.27251

DO - 10.1002/ajh.27251

M3 - Letter

C2 - 38343182

AN - SCOPUS:85185139592

SN - 0361-8609

VL - 99

SP - 785

EP - 788

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -

Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this